These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15970721)

  • 1. Factor XII auto-antibodies present in a patient with a B-cell lymphoma.
    Davidson SJ; Burman JF; Nicholson AG; Jones DW; Dusmet ME
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):365-7. PubMed ID: 15970721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII.
    Jones DW; Gallimore MJ; MacKie IJ; Harris SL; Winter M
    Br J Haematol; 2000 Sep; 110(3):721-6. PubMed ID: 10997986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome.
    Jones DW; MacKie IJ; Gallimore MJ; Winter M
    Br J Haematol; 2001 May; 113(2):550-2. PubMed ID: 11380430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy.
    Isbister GK; Maduwage K; Scorgie FE; Shahmy S; Mohamed F; Abeysinghe C; Karunathilake H; O'Leary MA; Gnanathasan CA; Lincz LF
    PLoS Negl Trop Dis; 2015; 9(8):e0003968. PubMed ID: 26296235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors].
    Morinaga S; Ide Y; Kusumoto M; Ogata M; Takaki K; Matsumoto E
    Rinsho Ketsueki; 2012 Jul; 53(7):716-20. PubMed ID: 22975775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection.
    Frauenknecht K; Lackner K; von Landenberg P
    Immunobiology; 2005; 210(10):799-805. PubMed ID: 16325500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lupus inhibitor: a study of its heterogeneity.
    Coots MC; Miller MA; Glueck HI
    Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration and mode of action of an inhibitor for activated Hageman factor (factor XIIa) of the intrinsic blood coagulation pathway from Schistosoma mansoni.
    Tsang VC; Damian RT
    Blood; 1977 Apr; 49(4):619-33. PubMed ID: 843620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus.
    Bertolaccini ML; Mepani K; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2007 Apr; 66(4):533-6. PubMed ID: 17020907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo.
    Pinckard RN; Tanigawa C; Halonen M
    J Immunol; 1975 Aug; 115(2):525-32. PubMed ID: 50367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CD8-positive diffuse large B-cell lymphoma].
    Noguchi M; Sakamoto N; Okumura K; Sato N; Yamada K; Isobe Y; Kato A; Oshimi K
    Rinsho Ketsueki; 2000 Jul; 41(7):591-5. PubMed ID: 11020983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired haemophilia A: two cases].
    de Vitry A; Valois A; Weinborn M; Dupuy-de Fonclare AL; Cuny JF; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2014; 141(6-7):441-5. PubMed ID: 24951143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies.
    Ma L; Sun P; Lin F; Diao G; Li C
    Thromb Res; 2013 Sep; 132(3):381-5. PubMed ID: 23953595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.